# Hackett Group, Inc.: financial statements, quarterly

HCKT · Nasdaq · CIK 1057379 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 26

Pages: [Overview](/companies/hckt.md) · [Financials](/companies/hckt/financials.md) · [Filings](/companies/hckt/filings.md) · [Insiders](/companies/hckt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hckt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-29) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-27) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-26) | Q1 FY2026 (2026-03-27) | Q2 FY2026 (2026-06-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [75.9](/filings/0000950170-25-030037.md) | [72.4](/filings/0000950170-25-030037.md) | [77.2](/filings/0001193125-26-082863.md) | [77.7](/filings/0001193125-26-082863.md) | [79.8](/filings/0001193125-26-082863.md) | [79.2](/filings/0001193125-26-082863.md) | [77.9](/filings/0001193125-26-209251.md) | [78.9](/filings/0001193125-26-335475.md) | [73.1](/filings/0001193125-26-082863.md) | [75.8](/filings/0001193125-26-082863.md) | [68.8](/filings/0001193125-26-209251.md) | [69.3](/filings/0001193125-26-335475.md) |
| Cost of revenue | $m | [45.6](/filings/0000950170-24-122386.md) | [43.1 d](/filings/0001193125-26-082863.md) | [47.2](/filings/0000950170-25-065870.md) | [47.2](/filings/0000950170-25-104196.md) | [48.2](/filings/0001193125-25-267231.md) | [48.0 d](/filings/0001193125-26-082863.md) | [50.0](/filings/0001193125-26-209251.md) | [50.9](/filings/0001193125-26-335475.md) | [43.4](/filings/0001193125-25-267231.md) | [44.1 d](/filings/0001193125-26-082863.md) | [39.5](/filings/0001193125-26-209251.md) | [41.6](/filings/0001193125-26-335475.md) |
| Gross profit | $m | [21.8](/filings/0000950170-24-122386.md) | [21.0 d](/filings/0000950170-24-023702.md) | [20.2](/filings/0000950170-24-055642.md) | [21.4](/filings/0000950170-24-092921.md) | [23.3](/filings/0000950170-24-122386.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [16.5](/filings/0000950170-24-122386.md) | [16.6 d](/filings/0001193125-26-082863.md) | [18.3](/filings/0000950170-25-065870.md) | [18.0](/filings/0000950170-25-104196.md) | [18.7](/filings/0001193125-25-267231.md) | [23.5 d](/filings/0001193125-26-082863.md) | [23.4](/filings/0001193125-26-209251.md) | [23.4](/filings/0001193125-26-335475.md) | [21.2](/filings/0001193125-25-267231.md) | [22.5 d](/filings/0001193125-26-082863.md) | [18.4](/filings/0001193125-26-209251.md) | [19.5](/filings/0001193125-26-335475.md) |
| Operating income | $m | [13.7](/filings/0000950170-25-030037.md) | [11.5](/filings/0000950170-25-030037.md) | [11.5](/filings/0001193125-26-082863.md) | [12.5](/filings/0001193125-26-082863.md) | [12.8](/filings/0001193125-26-082863.md) | [7.7](/filings/0001193125-26-082863.md) | [4.4](/filings/0001193125-26-209251.md) | [4.6](/filings/0001193125-26-335475.md) | [5.5](/filings/0001193125-26-082863.md) | [9.1](/filings/0001193125-26-082863.md) | [8.9](/filings/0001193125-26-209251.md) | [7.7](/filings/0001193125-26-335475.md) |
| Interest expense | $m | [0.8](/filings/0000950170-24-122386.md) | [0.6 d](/filings/0001193125-26-082863.md) | [0.5](/filings/0000950170-25-065870.md) | [0.5](/filings/0000950170-25-104196.md) | [0.4](/filings/0001193125-25-267231.md) | [0.2 d](/filings/0001193125-26-082863.md) | [0.2](/filings/0001193125-26-209251.md) | [0.4](/filings/0001193125-26-335475.md) | [0.4](/filings/0001193125-25-267231.md) | [0.7 d](/filings/0001193125-26-082863.md) | [1.0](/filings/0001193125-26-209251.md) | [1.2](/filings/0001193125-26-335475.md) |
| Income tax | $m | [3.5](/filings/0000950170-24-122386.md) | [3.0 d](/filings/0001193125-26-082863.md) | [2.3](/filings/0000950170-25-065870.md) | [3.3](/filings/0000950170-25-104196.md) | [3.8](/filings/0001193125-25-267231.md) | [3.9 d](/filings/0001193125-26-082863.md) | [1.1](/filings/0001193125-26-209251.md) | [2.6](/filings/0001193125-26-335475.md) | [2.5](/filings/0001193125-25-267231.md) | [2.8 d](/filings/0001193125-26-082863.md) | [3.6](/filings/0001193125-26-209251.md) | [2.1](/filings/0001193125-26-335475.md) |
| Net income | $m | [9.4](/filings/0000950170-25-030037.md) | [7.9](/filings/0000950170-25-030037.md) | [8.7](/filings/0001193125-26-082863.md) | [8.7](/filings/0001193125-26-082863.md) | [8.6](/filings/0001193125-26-082863.md) | [3.6](/filings/0001193125-26-082863.md) | [3.1](/filings/0001193125-26-335475.md) | [1.7](/filings/0001193125-26-335475.md) | [2.5](/filings/0001193125-26-082863.md) | [5.6](/filings/0001193125-26-082863.md) | [4.3](/filings/0001193125-26-335475.md) | [4.4](/filings/0001193125-26-335475.md) |
| Diluted EPS | $ per share | [0.34](/filings/0000950170-25-030037.md) | [0.28](/filings/0000950170-25-030037.md) | [0.32](/filings/0001193125-26-082863.md) | [0.31](/filings/0001193125-26-082863.md) | [0.31](/filings/0001193125-26-082863.md) | [0.12](/filings/0001193125-26-082863.md) | [0.11](/filings/0001193125-26-209251.md) | [0.06](/filings/0001193125-26-335475.md) | [0.09](/filings/0001193125-26-082863.md) | [0.21](/filings/0001193125-26-082863.md) | [0.17](/filings/0001193125-26-209251.md) | [0.18](/filings/0001193125-26-335475.md) |
| Basic EPS | $ per share | [0.35](/filings/0000950170-25-030037.md) | [0.29](/filings/0000950170-25-030037.md) | [0.32](/filings/0001193125-26-082863.md) | [0.32](/filings/0001193125-26-082863.md) | [0.31](/filings/0001193125-26-082863.md) | [0.13](/filings/0001193125-26-082863.md) | [0.11](/filings/0001193125-26-209251.md) | [0.06](/filings/0001193125-26-335475.md) | [0.09](/filings/0001193125-26-082863.md) | [0.21](/filings/0001193125-26-082863.md) | [0.17](/filings/0001193125-26-209251.md) | [0.18](/filings/0001193125-26-335475.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-29) | FY2023 (2023-12-29) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | FY2024 (2024-12-27) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | FY2025 (2025-12-26) | Q1 FY2026 (2026-03-27) | Q2 FY2026 (2026-06-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [9.9](/filings/0000950170-23-061037.md) | [21.0](/filings/0000950170-25-030037.md) | [13.0](/filings/0000950170-24-055642.md) | [19.1](/filings/0000950170-24-092921.md) | [10.0](/filings/0000950170-24-122386.md) | [16.4](/filings/0001193125-26-082863.md) | [9.2](/filings/0000950170-25-065870.md) | [10.1](/filings/0000950170-25-104196.md) | [13.9](/filings/0001193125-25-267231.md) | [18.2](/filings/0001193125-26-335475.md) | [6.1](/filings/0001193125-26-209251.md) | [14.2](/filings/0001193125-26-335475.md) |
| Current assets | $m | [75.3](/filings/0000950170-23-061037.md) | [75.4](/filings/0000950170-25-030037.md) | [73.7](/filings/0000950170-24-055642.md) | [80.3](/filings/0000950170-24-092921.md) | [74.9](/filings/0000950170-24-122386.md) | [76.3](/filings/0001193125-26-082863.md) | [75.0](/filings/0000950170-25-065870.md) | [80.2](/filings/0000950170-25-104196.md) | [80.4](/filings/0001193125-25-267231.md) | [83.9](/filings/0001193125-26-335475.md) | [81.7](/filings/0001193125-26-209251.md) | [84.5](/filings/0001193125-26-335475.md) |
| Total assets | $m | [181](/filings/0000950170-23-061037.md) | [181](/filings/0000950170-25-030037.md) | [179](/filings/0000950170-24-055642.md) | [188](/filings/0000950170-24-092921.md) | [191](/filings/0000950170-24-122386.md) | [193](/filings/0001193125-26-082863.md) | [192](/filings/0000950170-25-065870.md) | [201](/filings/0000950170-25-104196.md) | [201](/filings/0001193125-25-267231.md) | [206](/filings/0001193125-26-335475.md) | [204](/filings/0001193125-26-209251.md) | [209](/filings/0001193125-26-335475.md) |
| Current liabilities | $m | [47.0](/filings/0000950170-23-061037.md) | [49.9](/filings/0000950170-25-030037.md) | [44.3](/filings/0000950170-24-055642.md) | [46.8](/filings/0000950170-24-092921.md) | [49.5](/filings/0000950170-24-122386.md) | [53.1](/filings/0001193125-26-082863.md) | [47.2](/filings/0000950170-25-065870.md) | [47.0](/filings/0000950170-25-104196.md) | [42.7](/filings/0001193125-25-267231.md) | [48.8](/filings/0001193125-26-335475.md) | [43.5](/filings/0001193125-26-209251.md) | [43.6](/filings/0001193125-26-335475.md) |
| Total liabilities | $m | [100](/filings/0000950170-23-061037.md) | [91.3](/filings/0000950170-25-030037.md) | [85.8](/filings/0000950170-24-055642.md) | [85.3](/filings/0000950170-24-092921.md) | [79.8](/filings/0000950170-24-122386.md) | [77.7](/filings/0001193125-26-082863.md) | [77.3](/filings/0000950170-25-065870.md) | [80.7](/filings/0000950170-25-104196.md) | [99.0](/filings/0001193125-25-267231.md) | [138](/filings/0001193125-26-335475.md) | [138](/filings/0001193125-26-209251.md) | [140](/filings/0001193125-26-335475.md) |
| Long-term debt | $m | [43.7](/filings/0000950170-23-061037.md) | [32.7](/filings/0000950170-25-030037.md) | [30.7](/filings/0000950170-24-055642.md) | [26.7](/filings/0000950170-24-092921.md) | [19.7](/filings/0000950170-24-122386.md) | [12.7](/filings/0001193125-26-082863.md) | [17.8](/filings/0000950170-25-065870.md) | [22.8](/filings/0000950170-25-104196.md) | [43.8](/filings/0001193125-25-267231.md) | [75.8](/filings/0001193125-26-335475.md) | [78.8](/filings/0001193125-26-209251.md) | [80.9](/filings/0001193125-26-335475.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [80.8](/filings/0000950170-24-122386.md) | [90.1](/filings/0001193125-26-082863.md) | [93.5](/filings/0001193125-25-267231.md) | [102](/filings/0001193125-25-267231.md) | [111](/filings/0001193125-25-267231.md) | [116](/filings/0001193125-26-335475.md) | [114](/filings/0001193125-26-335475.md) | [120](/filings/0001193125-26-335475.md) | [102](/filings/0001193125-25-267231.md) | [68.1](/filings/0001193125-26-335475.md) | [66.0](/filings/0001193125-26-335475.md) | [68.2](/filings/0001193125-26-335475.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-29) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-27) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-26) | Q1 FY2026 (2026-03-27) | Q2 FY2026 (2026-06-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.2 d](/filings/0000950170-24-122386.md) | [25.6 d](/filings/0001193125-26-082863.md) | [2.8](/filings/0000950170-25-065870.md) | [13.7 d](/filings/0000950170-25-104196.md) | [10.6 d](/filings/0001193125-25-267231.md) | [20.6 d](/filings/0001193125-26-082863.md) | [4.2](/filings/0001193125-26-209251.md) | [5.6 d](/filings/0001193125-26-335475.md) | [11.4 d](/filings/0001193125-25-267231.md) | [19.1 d](/filings/0001193125-26-082863.md) | [(5.1)](/filings/0001193125-26-209251.md) | [15.2 d](/filings/0001193125-26-335475.md) |
| Capital expenditure | $m | [1.1 d](/filings/0000950170-24-122386.md) | [0.9 d](/filings/0001193125-26-082863.md) | [0.9](/filings/0000950170-25-065870.md) | [0.9 d](/filings/0000950170-25-104196.md) | [1.2 d](/filings/0000950170-24-122386.md) | [1.0 d](/filings/0001193125-26-082863.md) | [1.5](/filings/0001193125-26-209251.md) | [1.9 d](/filings/0001193125-26-335475.md) | [2.4 d](/filings/0001193125-25-267231.md) | [2.0 d](/filings/0001193125-26-082863.md) | [2.4](/filings/0001193125-26-209251.md) | [2.6 d](/filings/0001193125-26-335475.md) |
| Dividends paid | $m | [3.0 d](/filings/0000950170-24-122386.md) | [3.0 d](/filings/0001193125-26-082863.md) | [3.0](/filings/0000950170-25-065870.md) | [3.0 d](/filings/0000950170-25-104196.md) | [3.0 d](/filings/0001193125-25-267231.md) | [3.0 d](/filings/0001193125-26-082863.md) | [3.0](/filings/0001193125-26-209251.md) | [3.3 d](/filings/0001193125-26-335475.md) | [3.3 d](/filings/0001193125-25-267231.md) | [3.3 d](/filings/0001193125-26-082863.md) | [3.0](/filings/0001193125-26-209251.md) | [3.0 d](/filings/0001193125-26-335475.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-122386.md) | [0.0 d](/filings/0001193125-26-082863.md) | [1.1](/filings/0000950170-25-065870.md) | [0.0 d](/filings/0000950170-25-104196.md) | [1.7 d](/filings/0001193125-25-267231.md) | [3.6 d](/filings/0001193125-26-082863.md) | [6.2](/filings/0001193125-26-209251.md) | [4.3 d](/filings/0001193125-26-335475.md) | [17.4 d](/filings/0001193125-25-267231.md) | [41.2 d](/filings/0001193125-26-082863.md) | [3.0](/filings/0001193125-26-209251.md) | [3.9 d](/filings/0001193125-26-335475.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-29) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q1 FY2026 (2026-03-27) | Q2 FY2026 (2026-06-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [32.3](/filings/0000950170-23-061037.md) | [27.3](/filings/0000950170-24-055642.md) | [27.5](/filings/0000950170-24-092921.md) | [27.8](/filings/0000950170-24-122386.md) | [27.7](/filings/0000950170-25-065870.md) | [27.9](/filings/0000950170-25-104196.md) | [28.1](/filings/0001193125-25-267231.md) | [28.4](/filings/0001193125-26-209251.md) | [28.5](/filings/0001193125-26-335475.md) | [27.6](/filings/0001193125-25-267231.md) | [25.3](/filings/0001193125-26-209251.md) | [25.2](/filings/0001193125-26-335475.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 24,877,873 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001193125-26-335475.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.